 |
PDBsum entry 4w7s
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.6.4.13
- Rna helicase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP + H2O = ADP + phosphate + H+
|
 |
 |
 |
 |
 |
ATP
|
+
|
H2O
|
=
|
ADP
Bound ligand (Het Group name = )
matches with 81.25% similarity
|
+
|
phosphate
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Nucleic Acids Res
42:12885-12898
(2014)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure, mutational analysis and RNA-dependent ATPase activity of the yeast DEAD-box pre-mRNA splicing factor Prp28.
|
|
A.Jacewicz,
B.Schwer,
P.Smith,
S.Shuman.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Yeast Prp28 is a DEAD-box pre-mRNA splicing factor implicated in displacing U1
snRNP from the 5' splice site. Here we report that the 588-aa Prp28 protein
consists of a trypsin-sensitive 126-aa N-terminal segment (of which aa 1-89 are
dispensable for Prp28 function in vivo) fused to a trypsin-resistant C-terminal
catalytic domain. Purified recombinant Prp28 and Prp28-(127-588) have an
intrinsic RNA-dependent ATPase activity, albeit with a low turnover number. The
crystal structure of Prp28-(127-588) comprises two RecA-like domains splayed
widely apart. AMPPNP•Mg(2+) is engaged by the proximal domain, with proper and
specific contacts from Phe194 and Gln201 (Q motif) to the adenine nucleobase.
The triphosphate moiety of AMPPNP•Mg(2+) is not poised for catalysis in the
open domain conformation. Guided by the Prp28•AMPPNP structure, and that of
the Drosophila Vasa•AMPPNP•Mg(2+)•RNA complex, we targeted 20 positions in
Prp28 for alanine scanning. ATP-site components Asp341 and Glu342 (motif II) and
Arg527 and Arg530 (motif VI) and RNA-site constituent Arg476 (motif Va) are
essential for Prp28 activity in vivo. Synthetic lethality of double-alanine
mutations highlighted functionally redundant contacts in the ATP-binding
(Phe194-Gln201, Gln201-Asp502) and RNA-binding (Arg264-Arg320) sites.
Overexpression of defective ATP-site mutants, but not defective RNA-site
mutants, elicited severe dominant-negative growth defects.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |